FDA Inspection 1285696 — Aucta Pharmaceuticals, Inc.

Aucta Pharmaceuticals, Inc. — FEI 3015204529

The FDA completed an inspection of Aucta Pharmaceuticals, Inc. on Oct 3, 2025 in Piscataway, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 3, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Piscataway, NJ (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.